Scott Atkin is an accomplished business executive with extensive experience in all functions of business operations. Early in his career Scott founded multiple businesses and led them to successful exits. More recently he was an executive officer of a public company with responsibility for a portfolio of global businesses representing nearly $2BB in revenue. Throughout his career Scott has had accountability for all aspects of business operations. Scott has helped create and grow businesses through innovation and M&A activity and has extensive experience with integration of companies ranging from $5M to $600M in revenue.
Tim Bruemmer is a serial entrepreneur who has also experienced extensive success in large public companies. Tim’s passion is innovation and he has founded numerous high-technology companies in a variety of markets with multiple successful exits. He is also an intrapreneur, having led both a global engineering development organization as well as a global science and engineering research and development organization. In those roles, Tim was responsible for the development and launch of dozens of new products in regulated and research markets leading to > $1B in cumulative revenue and often resulting in market leading positions. In addition, Tim has extensive experience driving value creation through acquisitions, leading technical due-diligence efforts and integrating both acquired product lines and entire businesses into companies he founded and as an executive within a Fortune 500 company. These experiences, plus his experiences creating and managing organizational structures for manufacturing operations, product development and quality systems, provide Tim with an intimate understanding of the impact of corporate structure and culture on innovation. Tim has a B.S. in Chemical Engineering from the University of California at Berkeley, started his career at Eastman Kodak and has spent 35 years building and optimizing innovative organizations. These experiences make Tim uniquely capable in both intrapreneurial and entrepreneurial environments.
Paul Glyer has a long and successful history in financial management, strategy and M&A. Paul was an important member of the executive leadership team of a public company, helping drive growth from <$1B to nearly $4B in revenue through strategic M&A activity. While he held a variety of roles throughout his career, his last position was leading the Investor Relations, Business Development and Corporate Strategy functions. He has advised numerous clients and achieved an excellent reputation as a cogent business advisor.
Kim Klein Arvanites is an experienced and driven professional with over 20 years in the diagnostics and life sciences industries. Kim’s passion is helping companies successfully develop, launch, and sell new products by using her expertise in primary market research, segmentation analysis, market strategy, and competitive and technological analyses. Kim consistently demonstrated success as an account manager for life science and diagnostic companies. She then moved into strategic marketing, gathering voice of customer input around the world from physicians and laboratorians for molecular diagnostics products. Kim held senior marketing and business development positions for a number of major diagnostic competitors such as Beckman Coulter, Abbott, Qiagen and Sysmex Inostics. She also has considerable experience in program management, OEM alliance management, contract negotiations, and due diligence. Kim earned a B.S. degree in Biological Sciences and Molecular Biology from DePaul University
Richard S. Creager, Ph.D. is a recognized diagnostics new product development (NPD) and business leader who has a passion for building high performance global teams and using their expertise to deliver breakthrough products and build successful businesses. Richard has diverse experience developing new products, new technologies and new business models for diagnostic, laboratory services and B2B companies. He has developed new businesses that range from $25 million to more than $1 billion in annual sales. In addition, he managed large innovation teams and business units and has significant experience in developing market strategies, product and technology pipelines, portfolio management, licensing and development partnerships. Using his expertise in organizational design, talent management, product development, program management, and quality & design control systems, Richard works with companies to achieve the dexterity they require to get ahead of their competitors. Dr. Creager is the former chief science officer and executive officer for Beckman Coulter. He holds B.S. and M.S. degrees in biology and earned his Ph.D. degree in Microbiology at the University of Pittsburgh School of Medicine.
Bill Glauser is a marketing strategist and business development executive with a successful record of identifying and driving adoption of innovative solutions within life science industry by gaining primal understanding of customer needs. He is a recognized innovator in Voice of Customer studies to help clients identify “white space” for their new product development as well as to sharpen value propositions for attracting financing and building Challenger-based sales teams. He served as Senior Vice President at Seven Bridges Genomics where he led business strategy for introducing cloud-enabled, reproducible biomedical data analysis to the clinical diagnostic, biotech, and research hospital markets. He also led initiatives in pharmacogenomics leveraging big data to address seminal issues in drug re-purposing and acquired resistance in oncology. Prior to that, he was Vice President of Strategic Business at Schrodinger, LLC, a leader in predictive software modeling and drug discovery services. There he created strategic partnerships with major pharmaceutical companies that provided the basis for Schrödinger LLC’s entry and expansion strategies and also led voice of customer campaigns to inform disruptive innovation in new product development.
Bill held a postdoctoral fellowship at the University of California, Berkeley in theoretical chemistry after earning a Ph.D. from the University of South Florida in computational chemistry. He then earned an MBA in Technology Evaluation and Commercialization from North Carolina State University, where he co-founded a genomics company specializing in the production of difficult-to-express proteins used as both drug targets and therapies.
Bill Kline is the Associate Dean of Innovation and a Professor of Engineering Management at Rose-Hulman. Prior to joining Rose-Hulman, his industry experience includes roles as co-founder and Chief Operating Officer at Montronix and as development manager at Kennametal. He joined Rose-Hulman in 2001 and his teaching and professional interests include systems engineering, design, quality, innovation, and entrepreneurship. He served for five years as the director of the Rose-Hulman Ventures program, providing technical services to client companies in innovation stage and commercialization projects. In his current role as Associate Dean of Innovation, he focuses on campus innovation and entrepreneurship initiatives including the Branam Innovation Center, the Escalate entrepreneurship program, and engagement activities including expanded alumni, corporate, and community partnerships.
As a member of the founding team at Inside Out Innovations, Bill co-develops all workshop offerings. He is an experienced workshop presenter and the co-creator of the Innovation Canvas. His years of industrial and teaching experience allow him to offer unique insight into product-market connections and value creation at all Inside Out Innovations workshops.